$44.18
0.85%
NYSE, Sep 25, 04:00 pm EDT. Closed.
ISIN
NL0015002CX3
Symbol
QGEN

Qiagen Target price 2026 - Analyst rating & recommendation

Qiagen Classifications & Recommendation

Buy
48%
Hold
52%

Qiagen Price Target

Target Price $46.92
Price $44.18
Potential
Number of Estimates 18
18 Analysts have issued a price target Qiagen 2027 . The average Qiagen target price is $46.92. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 23 analysts: 11 Analysts recommend Qiagen to buy, 12 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Qiagen stock has an average upside potential 2027 of . Most analysts recommend the Qiagen stock at Hold.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 2.09 2.18
5.65% 4.21%
EBITDA Margin 26.77% 37.02%
4.95% 38.30%
Net Margin 20.33% 23.87%
381.10% 17.42%

25 Analysts have issued a sales forecast Qiagen 2026 . The average Qiagen sales estimate is

$2.2b
unlock
. This is
3.70% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.3b 7.70%
unlock
, the lowest is
$2.1b 1.02%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $2.1b 5.65%
2026
$2.2b 4.21%
unlock
2027
$2.3b 5.05%
unlock
2028
$2.4b 5.55%
unlock
2029
$2.8b 15.53%
unlock
2030
$2.9b 4.19%
unlock

22 Analysts have issued an Qiagen EBITDA forecast 2026. The average Qiagen EBITDA estimate is

$806m
unlock
. This is
51.85% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$921m 73.39%
unlock
, the lowest is
$701m 32.10%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $559m 10.88%
2026
$806m 44.13%
unlock
2027
$864m 7.12%
unlock
2028
$927m 7.28%
unlock
2029
$993m 7.22%
unlock
2030
$1.0b 4.98%
unlock

EBITDA Margin

2025 26.77% 4.95%
2026
37.02% 38.30%
unlock
2027
37.75% 1.97%
unlock
2028
38.37% 1.64%
unlock
2029
35.61% 7.19%
unlock
2030
35.88% 0.76%
unlock

24 Qiagen Analysts have issued a net profit forecast 2026. The average Qiagen net profit estimate is

$520m
unlock
. This is
27.04% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$690m 68.45%
unlock
, the lowest is
$455m 11.24%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $425m 408.29%
2026
$520m 22.39%
unlock
2027
$561m 7.94%
unlock
2028
$609m 8.50%
unlock
2029
$647m 6.26%
unlock
2030
$694m 7.18%
unlock

Net Margin

2025 20.33% 381.10%
2026
23.87% 17.42%
unlock
2027
24.53% 2.76%
unlock
2028
25.22% 2.81%
unlock
2029
23.19% 8.05%
unlock
2030
23.86% 2.89%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 1.94 2.52
385.00% 29.90%
P/E 17.54
EV/Sales 4.57

24 Analysts have issued a Qiagen forecast for earnings per share. The average Qiagen EPS is

$2.52
unlock
. This is
28.57% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$3.34 70.41%
unlock
, the lowest is
$2.21 12.76%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $1.94 385.00%
2026
$2.52 29.90%
unlock
2027
$2.72 7.94%
unlock
2028
$2.95 8.46%
unlock
2029
$3.13 6.10%
unlock
2030
$3.36 7.35%
unlock

P/E ratio

Current 22.54 15.61%
2026
17.54 22.19%
unlock
2027
16.25 7.35%
unlock
2028
14.98 7.82%
unlock
2029
14.10 5.87%
unlock
2030
13.15 6.74%
unlock

Based on analysts' sales estimates for 2026, the Qiagen stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.74 7.42%
2026
4.57 3.58%
unlock
2027
4.35 4.81%
unlock
2028
4.12 5.26%
unlock
2029
3.57 13.44%
unlock
2030
3.42 4.02%
unlock

P/S ratio

Current 4.33 11.23%
2026
4.18 3.56%
unlock
2027
3.98 4.81%
unlock
2028
3.77 5.26%
unlock
2029
3.26 13.44%
unlock
2030
3.13 4.02%
unlock

Current Qiagen Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
UBS
Locked
➜
Locked
Locked Sep 09 2026
Citigroup
Locked
➜
Locked
Locked Aug 10 2026
JP Morgan
Locked
➜
Locked
Locked Aug 07 2026
Barclays
Locked
➜
Locked
Locked Aug 07 2026
Morgan Stanley
Locked
➜
Locked
Locked Jun 23 2026
Stifel
Locked
➜
Locked
Locked May 18 2026
TD Cowen
Locked
➜
Locked
Locked May 07 2026
Analyst Rating Date
Locked
UBS:
Locked
➜
Locked
Sep 09 2026
Locked
Citigroup:
Locked
➜
Locked
Aug 10 2026
Locked
JP Morgan:
Locked
➜
Locked
Aug 07 2026
Locked
Barclays:
Locked
➜
Locked
Aug 07 2026
Locked
Morgan Stanley:
Locked
➜
Locked
Jun 23 2026
Locked
Stifel:
Locked
➜
Locked
May 18 2026
Locked
TD Cowen:
Locked
➜
Locked
May 07 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today